IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL

NCT06768905 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non Hodgkin Lymphoma
Diffuse Large B Cell Lymphoma

Interventions

DRUG: Iomab-B
DRUG: CAR-T cell

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]